Overexpression and clinicopathological significance of cullin-2 in hepatocellular carcinoma progression

Read full text Summarise with VIRAT
Authors: Pan Tang, Qiu-Hong Nong, Kun-Hua Xiong, Huan-Huan Tang, Bei-Bei Huang, Guang-Lei Huang, Qi Li, Shi-Pei He, Gang Chen, Zhen-Bo Feng, Jian-Di Li
Cited by: 0
References: 32

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND Hepatocellular carcinoma (HCC) is a life-threatening malignant tumor with complex pathogenesis and limited treatment. The core clinical protocols include surgical resection, liver transplantation, local ablation, transcatheter arterial chemoembolization, targeted therapy, immunotherapy, and systemic chemotherapy. As a core component of the Cullin-RING E3 ubiquitin ligase complex, Cullin-2 (CUL2) plays a key role in cell cycle regulation. However, its clinical significance and molecular mechanisms in HCC remain unclear. AIM To systematically elucidate the expression pattern, clinical significance, and molecular mechanism of CUL2 in HCC, evaluate its potential as a diagnostic biomarker and therapeutic target, this study integrated large-scale omics data and clustered regularly interspaced short palindromic repeats (CRISPR) screening technology. METHODS CUL2 protein expression in 125 HCC tissue specimens was assessed via immunohistochemistry. We integrated global HCC microarray and high-throughput sequencing datasets from a multicenter cohort (9283 specimens: 5204 HCC and 4079 non-tumor tissues) for CUL2 mRNA expression analysis. Single-cell RNA sequencing and spatial transcriptomics were employed to characterize CUL2 expression patterns. The correlation between CUL2 expression and clinicopathological parameters was analyzed in the Cancer Genome Atlas-LIHC cohort (n = 371). Gene set enrichment analysis (GSEA) was performed using Hallmark, Kyoto Encyclopedia of Genes and Genomes, and Gene Ontology gene sets. CRISPR functional screening and gene co-expression network analysis were applied to elucidate molecular mechanisms. RESULTS CUL2 was significantly overexpressed in HCC tissues at both mRNA and protein levels. Integrated multicenter analysis (n = 5204) confirmed marked CUL2 mRNA up-regulation (standardized mean difference = 0.70, P < 0.05) with moderate diagnostic value (area under the curve = 0.78). Patients with high CUL2 expression showed significantly reduced overall survival (approximately 4.1 years shorter, P = 0.0011). CUL2 expression correlated with clinicopathological features, including tumor stage. GSEA revealed significant enrichment of E2F targets, G2/M checkpoint, and MYC signaling pathways in CUL2-high tumors. CRISPR-mediated CUL2 knockout inhibited growth in 20 of 21 HCC cell lines. Co-expression analysis identified 190 CUL2-correlated genes enriched in nuclear division, cell cycle transition, and nucleocytoplasmic transport pathways, indicating CUL2 promotes HCC progression through proliferation and migration-related mechanisms. CONCLUSION CUL2 is significantly overexpressed in HCC tissues, which highlights its potential as a molecular biomarker and a promising therapeutic target for HCC management.

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis Ubiquitin and proteasome pathways Cancer-related molecular mechanisms research

Publication details

Journal / source
World Journal of Hepatology
Volume
18
Issue
3
Publication date
26 March 2026
Language
EN